首页> 美国卫生研究院文献>Journal of Gynecologic Oncology >A phase II open-labeled single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303 DOENCA trial

【2h】

A phase II open-labeled single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303 DOENCA trial

机译：II期开放标记单臂研究剂量 - 致密紫杉醇加上先进或复发子宫子宫内膜癌症治疗：Kcog-G1303Doenca试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

To determine the safety and efficacy of dose-dense (dd) paclitaxel (PTX) and carboplatin (CBDCA) in treating advanced or recurrent endometrial cancer.

机译：确定剂量 - 致密（DD）紫杉醇（PTX）和卡铂（CBDCA）治疗晚期或复发子宫内膜癌的安全性和有效性。

著录项

期刊名称 Journal of Gynecologic Oncology
作者
Kensuke Hori; Shin Nishio; Kimio Ushijima; Yuka Kasamatsu; Eiji Kondo; Kazuhiro Takehara; Kimihiko Ito;
展开▼
作者单位

展开▼
年(卷),期 2021(32),4
年度 2021
页码 e64
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学;妇产科学;
关键词

机译：子宫内膜癌;化疗;紫杉醇;卡铂;

相似文献

外文文献
中文文献

1. Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2-A randomized phase II trial [J] . Lorusso D., Ferrandina G., Colombo N., Gynecologic Oncology: An International Journal . 2019,第3期

机译：Carboplatin-PAClitaxel与Carboplatin-PAClitaxel-Bevacizumab在先进或复发子宫内膜癌症中：MITO END-2-A随机期II试验
2. A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer [J] . Aghajanian Carol, Filiaci Virginia, Dizon Don S., Gynecologic Oncology: An International Journal . 2018,第2期

机译：前线紫杉醇/卡铂/贝伐单抗，紫杉醇/卡巴铂/ Temssirolimus，或在先进/复发子宫内膜癌症中的Ixabepilone / Carboplatin / Bevacizumab的II类研究
3. Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II-IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016). [J] . K Harano, F Terauchi, N Katsumata, Annals of oncology: official journal of the European Society for Medical Oncology . 2014,第1期

机译：每周剂量密集的紫杉醇和卡铂与常规紫杉醇和卡铂作II-IV期卵巢癌一线治疗的随机III期试验的生活质量结果：日本妇科肿瘤学小组试验（JGOG3016）。
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. A Phase II Study of Frontline Paclitaxel/Carboplatin/Bevacizumab Paclitaxel/Carboplatin/Temsirolimus or Ixabepilone/Carboplatin/Bevacizumab in Advanced/Recurrent Endometrial Cancer [O] . Carol Aghajanian, Virginia Filiaci, Don S. Dizon, -1

机译：前线紫杉醇/卡铂/贝伐单抗紫杉醇/卡铂/替米罗莫司或伊沙贝比隆/卡铂/贝伐单抗在晚期/复发性子宫内膜癌中的II期研究
7. A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer [O] . Carol Aghajanian, Virginia Filiaci, Don S. Dizon, 2018

机译：前线紫杉醇/卡铂/贝伐单抗，紫杉醇/卡铂/ Temssirolimus或Ixabepilone / carboplatin / Bevacizumab在先进/复发子宫内膜癌中的II期研究

A phase II open-labeled single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303 DOENCA trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅